BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
49.90
+0.23 (0.46%)
At close: Jan 21, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 21.09 billion as of January 22, 2026. Its market cap has increased by 65.81% in one year.
Market Cap
21.09B
Enterprise Value
22.91B
Revenue
1.18B
Ranking
n/a
PE Ratio
339.81
Stock Price
49.90
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 21.09B, an increase of 68.08%. That is a compound annual growth rate of 8.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 21.09B | 1.71% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xiamen Amoytop Biotech | 30.66B |
| Hualan Biological Engineering | 28.01B |
| Yili Chuanning Biotechnology | 24.60B |
| Suzhou Zelgen Biopharmaceuticals | 24.18B |
| DaShenLin Pharmaceutical Group | 22.13B |
| Inner Mongolia Furui Medical Science | 21.07B |
| Sinocelltech Group | 20.69B |
| Jinyu Bio-technology | 19.32B |